Restatement of Previously Issued Financial Statements (Tables)

6 Months Ended

Dec. 31, 2020

Condensed Financial Information Disclosure [Abstract]

Schedule of condensed balance sheet

	As of December 31, 2020
	As Previously Reported			Restatement Adjustment			As Restated
Unaudited Condensed Balance Sheet
Total assets	$	118,001,829		$	-		$	118,001,829
Liabilities and shareholders’ equity
Total current liabilities	$	392,964		$	-		$	392,964
Deferred underwriting commissions		4,025,000			-			4,025,000
Derivative warrant liabilities		-			7,411,400			7,411,400
Total liabilities		4,417,964			7,411,400			11,829,364
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders’ equity		108,583,858			(7,411,400	)		101,172,458
Preference shares - $0.0001 par value		-			-			-
Class A ordinary shares - $0.0001 par value		80			73			153
Class B ordinary shares - $0.0001 par value		288			-			288
Additional paid-in-capital		5,179,326			130,577			5,309,903
Accumulated deficit		(179,687	)		(130,650	)		(310,337	)
Total shareholders’ equity		5,000,007			-			5,000,007
Total liabilities and shareholders’ equity	$	118,001,829		$	-		$	118,001,829

Schedule of condensed statement of operations

	For the Three Months Ended December 31, 2020
	As Previously Reported			Restatement Adjustment			As Restated
Unaudited Condensed Statement of Operations
Loss from operations	$	(160,421	)	$	-		$	(160,421	)
Other (expense) income:
Change in fair value of derivative warrant liabilities		-			184,000			184,000
Financing costs		-			(314,650	)		(314,650	)
Gain on investments Held in Trust Accounts		3,736			-			3,736
Total other (expense) income		3,736			(130,650	)		(126,914	)
Net loss	$	(156,685	)	$	(130,650	)	$	(287,335	)
Basic and Diluted weighted-average Class B ordinary shares outstanding		2,926,250			-			2,926,250
Basic and Diluted net loss per Class B share	$	(0.05	)	$			$	(0.10	)

	For the Six Months Ended December 31, 2020
	As Previously Reported			Restatement Adjustment			As Restated
Unaudited Condensed Statement of Operations
Loss from operations	$	(176,156	)	$	-		$	(176,156	)
Other (expense) income:
Change in fair value of derivative warrant liabilities		-			184,000			184,000
Financing costs		-			(314,650	)		(314,650	)
Gain on investments Held in Trust Accounts		3,736			-			3,736
Total other (expense) income		3,736			(130,650	)		(126,914	)
Net loss	$	(172,420	)	$	(130,650	)	$	(303,070	)
Basic and Diluted weighted-average Class B ordinary shares outstanding		2,713,182			-			2,713,182
Basic and Diluted net loss per Class B share	$	(0.06	)	$			$	(0.11	)

Schedule of condensed statement of cash flows

	For the Six Months Ended December 31, 2020
	As Previously Reported			Restatement Adjustment			As Restated
Unaduited Condensed Statement of Cash Flows
Net loss	$	(172,420	)	$	(130,650	)	$	(303,070	)
Change in fair value of derivative warrant liabilities	$	-		$	(184,000	)	$	(184,000	)
Financing Costs - derivative warrant liabilities	$	-		$	314,650		$	314,650
Initial value of Class A ordinary shares subject to possible redemption	$	93,922,703		$	(7,595,397	)	$	86,327,306
Change in fair value of Class A ordinary shares subject to possible redemption	$	14,661,152		$	(13,085,598	)	$	1,575,554